Peter M. Hecht
2012 - Ironwood Pharmaceuticals
In 2012, Peter M. Hecht earned a total compensation of $2.3M as Chief Executive Officer at Ironwood Pharmaceuticals, a 107% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,208,660 |
|---|---|
| Salary | $100,000 |
| Other | $7,440 |
| Total | $2,316,100 |
Hecht received $2.2M in option awards, accounting for 95% of the total pay in 2012.
Hecht also received $100K in salary and $7.4K in other compensation.
Rankings
In 2012, Peter M. Hecht's compensation ranked 3,066th out of 11,487 executives tracked by ExecPay. In other words, Hecht earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,066 out of 11,487 | 73rd |
Division Manufacturing | 1,071 out of 4,253 | 75th |
Major group Chemicals And Allied Products | 241 out of 1,198 | 80th |
Industry group Drugs | 141 out of 920 | 85th |
Industry Pharmaceutical Preparations | 114 out of 700 | 84th |
Source: SEC filing on April 17, 2015.
Hecht's colleagues
We found three more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2012.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019